Travere Therapeutics (TVTX) PT Raised to $50 at Wells Fargo

May 6, 2026 8:44 AM

Wells Fargo analyst Mohit Bansal raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $50.00 (from $40.00) while maintaining a Overweight rating.

No results found